Idelvion albutrepenonacog alfa regulatory update

CSL said Japan approved Idelvion albutrepenonacog alfa for bleeding in hemophilia B patients. The product is indicated as routine prophylaxis to prevent or reduce the frequency of bleeding episodes; o...